Jefferies said it expects Mankind Pharma's first and second quarters to be steep quarters. It said the company's prescription ...

CNBC's "Squawk on the Street" team is joined by David Zervos, chief market strategist at Jefferies, to discuss who the next ...

Key Takeaways Oracle shares are on pace to hit a record-high closing price Tuesday.Jefferies raised its price target for ...

Sunrun upgraded at Jefferies, citing a "renewed sense of confidence driven by firmed up IRA providing visibility into outer ...

After the release of jobless claims data for last week, Jefferies economist Thomas Simons and analyst Sam Saliba have come out with a view that poi ...

Samana concludes that if HubSpot delivers a solid Q2, the company could regain its growth narrative and shift investor ...

Young Li from Jefferies maintained a Buy rating on the stock, citing the company’s strategic initiatives and market ...

Nordex reported a record-breaking second-quarter order intake, significantly surpassing market expectations and reaffirming strong demand momentum in the wind turbine sector, according to Jefferies ...

Analysts think Disney's operating income may grow for the first time in nearly a decade because of strong tourism and ...

Jefferies identifies Varun Beverages, Asian Paints, and Hindustan Unilever as potential contra bets despite recent challenges ...

While valuations for these stocks are not cheap, Jefferies believes the current pricing has already factored in caution ...

Jefferies rated Hold with $52 PT, citing balanced growth vs. macro headwinds. Insights on costs, margins, and deal flow.